Merck & Co., Inc.
145.27USD
-1.9700 (-1.34%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MRK.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.09▼ | $2.28 | 1 | 7 |
| Next quarter | $1.95▼ | $1.99 | 3 | 5 |
| Current year | $2.65▼ | $2.74 | 0 | 10 |
| Next year | $9.24▼ | $9.66 | 1 | 10 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.26 | -$0.13 | +0.13 (+49.4%) |
| 2026-03-31 | -$1.47 | -$1.28 | +0.19 (+13.2%) |
| 2025-12-31 | $2.01 | $2.04 | +0.03 (+1.5%) |
| 2025-09-30 | $2.35 | $2.58 | +0.23 (+9.9%) |
375 ratings from 39 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | $125 $145 | Oct 12, 2026 |
| RBC Capital | Maintained | Sector Perform | $150 $145 | Oct 12, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $120 $145 | Oct 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $179 $177 | Oct 7, 2026 |
| JP Morgan | Maintained | Overweight | $150 $165 | Oct 5, 2026 |
| Scotiabank | Maintained | Sector Outperform | $155 $180 | Sep 29, 2026 |
| HSBC | Maintained | Buy | $150 $172 | Sep 10, 2026 |
| Leerink Partners | Maintained | Outperform | $127 $161 | Sep 9, 2026 |
| Guggenheim | Maintained | Buy | $146 $170 | Sep 8, 2026 |
| Wells Fargo | Maintained | Overweight | $150 $170 | Sep 4, 2026 |
| Wolfe Research | Maintained | Outperform | $155 $180 | Aug 25, 2026 |
| Argus Research | Maintained | Buy | $145 $170 | Aug 25, 2026 |
| Goldman Sachs | Maintained | Buy | $140 $160 | Aug 21, 2026 |
| BMO Capital | Maintained | Outperform | $142 $170 | Aug 20, 2026 |
| UBS | Maintained | Buy | $145 $175 | Aug 20, 2026 |
| RBC Capital | Downgraded from Outperform | Sector Perform | $142 $150 | Aug 20, 2026 |
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $116 $179 | Aug 20, 2026 |
| Daiwa Capital | Upgraded from Neutral | Outperform | $120 $143 | Aug 12, 2026 |
| Argus Research | Maintained | Buy | $130 $145 | Aug 11, 2026 |
| Guggenheim | Maintained | Buy | $145 $146 | Aug 5, 2026 |
| Barclays | Maintained | Overweight | $140 $150 | Jul 29, 2026 |
| JP Morgan | Maintained | Overweight | $135 $140 | Jul 13, 2026 |
| BMO Capital | Maintained | Outperform | $135 $142 | Jul 13, 2026 |
| Guggenheim | Maintained | Buy | $140 $145 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $112 $113 | Jul 9, 2026 |
81 filings from 19 insiders · 16 buy / 7 sell over 6m
Officers and directors of MRK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Seidman Christine EDirector | GrantPhantom Stock | 55.915 | $145.31 | $8k | Sep 30, 2026 |
| Karsanbhai Surendralal LancaDirector | GrantPhantom Stock | 111.83 | $145.31 | $16k | Sep 30, 2026 |
| Coe Mary EllenDirector | GrantPhantom Stock | 206.455 | $145.31 | $30k | Sep 30, 2026 |
| GUINDO CHIRFIOfficer | Sell | 10.0k | $135.00 | $1.35M | Aug 13, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Sell | 80.3k | $133.46 | $10.72M | Aug 12, 2026 |
| DELUCA RICHARD ROBERT JR.Officer | Sell | 45.3k | $130.43 | $5.94M | Aug 12, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Exercise | 54.9k | $84.71 | $6.03M | Aug 12, 2026 |
| GUINDO CHIRFIOfficer | Sell | 15.0k | $131.00 | $1.97M | Aug 6, 2026 |
| DELUCA RICHARD ROBERT JR.Officer | Sell | 6.0k | $130.23 | $789k | Aug 6, 2026 |
| MARALDO DAVID R.Officer | Sell | 18.7k | $128.72 | $2.41M | Aug 5, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Sell | 52.8k | $128.77 | $6.81M | Aug 5, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Exercise | 52.8k | $73.73 | $3.94M | Aug 5, 2026 |
| MARALDO DAVID R.Officer | Exercise | 18.7k | $73.73 | $1.54M | Aug 5, 2026 |
| SMART DALTON E. IIIOfficer | Exercise | 383 | $112.16 | $43k | May 1, 2026 |
| MARALDO DAVID R.Officer | Exercise | 552 | $112.16 | $62k | May 1, 2026 |
| SMART DALTON E. IIIOfficer | Exercise | 1.4k | $110.03 | $155k | Apr 30, 2026 |
| LARSON BETTY DOfficer | Other | 13.4k | — | — | Apr 30, 2026 |
| WILLIAMS DAVID MICHAELChief Technology Officer | Other | 1.4k | — | — | Apr 29, 2026 |
| LITCHFIELD CAROLINEChief Financial Officer | Other | 3.9k | — | — | Apr 29, 2026 |
| ZACHARY JENNIFER LGeneral Counsel | Other | 3.0k | — | — | Apr 29, 2026 |
No analyst notes on MRK yet.
Analyst Ratings
25 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 5 | 14 | 8 | 0 | 0 | Buy2.11 |
| 1 mo ago | 5 | 14 | 8 | 0 | 0 | Buy2.11 |
| 2 mo ago | 5 | 15 | 8 | 0 | 0 | Buy2.11 |
| 3 mo ago | 4 | 15 | 8 | 0 | 1 | Buy2.25 |
Members whose judged calls on MRK have played out most reliably.
No settled calls on MRK yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice